%0 Journal Article
%T Trends of medicare reimbursement for breast cancer and reconstructive surgery.
%A Siotos C
%A Seu MY
%A Frauchiger-Ankers R
%A Delmastro LE
%A O'Donoghue C
%A Madrigrano A
%A Alvarado R
%A Perez CB
%A Hood KC
%A Shenaq DS
%A Kokosis G
%A Kurlander DE
%J J Plast Reconstr Aesthet Surg
%V 94
%N 0
%D 2024 Jul 4
%M 38759511
%F 3.022
%R 10.1016/j.bjps.2024.04.064
%X This study evaluated trends in Medicare reimbursement for commonly performed breast oncologic and reconstructive procedures. Average national relative value units (RVUs) for physician-based work, facilities, and malpractice were collected along with the corresponding conversion factors for each year. From 2010 to 2021, there was an overall average decrease of 15% in Medicare reimbursement for both breast oncology (-11%) and reconstructive procedures (-16%). Based on these findings, breast and reconstructive surgeons should advocate for reimbursement that better reflects the costs of their practice.